000168957 001__ 168957
000168957 005__ 20240229133632.0
000168957 0247_ $$2doi$$a10.1038/s41375-021-01298-y
000168957 0247_ $$2pmid$$apmid:34031532
000168957 0247_ $$2ISSN$$a0887-6924
000168957 0247_ $$2ISSN$$a1476-5551
000168957 0247_ $$2altmetric$$aaltmetric:106374300
000168957 037__ $$aDKFZ-2021-01159
000168957 041__ $$aEnglish
000168957 082__ $$a610
000168957 1001_ $$00000-0001-7803-0814$$aSalwender, Hans$$b0
000168957 245__ $$aLong-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial.
000168957 260__ $$aLondon$$bSpringer Nature$$c2021
000168957 3367_ $$2DRIVER$$aarticle
000168957 3367_ $$2DataCite$$aOutput Types/Journal article
000168957 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1634305689_1828
000168957 3367_ $$2BibTeX$$aARTICLE
000168957 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168957 3367_ $$00$$2EndNote$$aJournal Article
000168957 500__ $$a2021 Oct;35(10):3007-3011
000168957 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000168957 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000168957 7001_ $$aElmaagacli, Ahmet$$b1
000168957 7001_ $$aMerz, Maximilian$$b2
000168957 7001_ $$0P:(DE-He78)b97fc5666ea8f9db9ef499de6b2397cf$$aMiah, Kaya$$b3$$udkfz
000168957 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b4$$udkfz
000168957 7001_ $$aHaenel, Mathias$$b5
000168957 7001_ $$aJehn, Christian$$b6
000168957 7001_ $$00000-0002-6226-1252$$aMai, Elias K$$b7
000168957 7001_ $$aBertsch, Uta$$b8
000168957 7001_ $$aBlau, Igor W$$b9
000168957 7001_ $$aScheid, Christof$$b10
000168957 7001_ $$aHose, Dirk$$b11
000168957 7001_ $$aSeckinger, Anja$$b12
000168957 7001_ $$aJauch, Anna$$b13
000168957 7001_ $$aRaab, Marc S$$b14
000168957 7001_ $$aLuntz, Steffen P$$b15
000168957 7001_ $$aBesemer, Britta$$b16
000168957 7001_ $$aMunder, Markus$$b17
000168957 7001_ $$aBrossart, Peter$$b18
000168957 7001_ $$aFuhrmann, Stephan$$b19
000168957 7001_ $$aLindemann, Hans-Walter$$b20
000168957 7001_ $$00000-0001-9422-6614$$aWeisel, Katja$$b21
000168957 7001_ $$aDuerig, Jan$$b22
000168957 7001_ $$aGoldschmidt, Hartmut$$b23
000168957 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/s41375-021-01298-y$$n10$$p3007-3011$$tLeukemia$$v35$$x1476-5551$$y2021
000168957 909CO $$ooai:inrepo02.dkfz.de:168957$$pVDB
000168957 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b97fc5666ea8f9db9ef499de6b2397cf$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000168957 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000168957 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000168957 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000168957 9141_ $$y2021
000168957 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2019$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-29
000168957 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bLEUKEMIA : 2019$$d2021-01-29
000168957 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000168957 980__ $$ajournal
000168957 980__ $$aVDB
000168957 980__ $$aI:(DE-He78)C060-20160331
000168957 980__ $$aUNRESTRICTED